Ethnic variation and in vivo effects of the -93t→g promoter variant in the lipoprotein lipase gene

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2672-2678

  Ehrenborg, Ewa ^a   Clee, Susanne M ^a   Pimstone, Simon N ^a   Reymer, Paul W A ^b   Benlian, Pascale ^a   Hoogendijk, Christiaan F ^c   Davis, Henry J ^c   Bissada, Nagat ^a   Miao, Li ^a   Gagné, S Eric ^a   Greenberg, L Jacquie ^d   Henry, Ronald ^b   Henderson, Howard ^e   Ordovas, José M ^f   Schaefer, Ernst J ^f   Kastelein, Johannes J P ^b   Kotze, Maritha J ^c   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^f TUFTS UNIVERSITY   (United States)

Author keywords

Ethnic variation; Lipids; Lipoprotein lipase; Mutation; Promoter

Indexed keywords

LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CAUCASIAN; CHINESE; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; HUMAN; HYPOLIPEMIA; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROMOTER REGION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 17344367302     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2672     Document Type: Article

References (24)

1. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York: McGraw-Hill; 1995;2:1913-1932.
2. Hayden MR, Ma Y. Molecular genetics of lipoprotein lipase deficiency. Mol Cell Biochem. 1990;113:171-176.
3. Benlian P. In: INSERM, ed. La Lipoprotéine Lipase, Enzyme du Remodelage des Lipoprotéines Riches en Triglycerides. Génétique et dyslipidémies. Paris: INSERM; 1996:79-89.
4. Reymer PWA, Gagné SE, Groenemeyer BE, Zhang H, Forsythe I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 1995;10:29-34.
5. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BJ, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud PJ. A common variant in the gene for lipoprotein lipase (Asp9Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscl Thromb Vasc Biol. 1995;15:468-478.
6. Mailly F, Fisher RM, Nicaud V, Luong L-A, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis. 1996;122:21-28.
7. Reymer PWA, Groenemeyer BE, Gagné SE, Miao L, Appelman EEG, Seidel JC, Kromhout D, Bijvoet SM, van de Oever K, Bruin T, Hayden MR, Kastelein JJP. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet. 1995;4:1543-1549.
8. Jukema JW, van Boven AJ, Groenemeier B, Zwinderman AH, Reiber JHC, Bruschke AVG, Henneman JA, Moelhoek GP, Bruin T, Jansen H, Gagné E, Hayden MR, Kastelein JJP. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 1996;94:1913-1918.
9. Fischer RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res. 1995;36:2104-2112.
10. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou J-P, Bard J-M, Fruchart J-C, Apfelbaum M, Cambien F, Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res. 1995;36:2141-2146.
11. Zhang H, Henderson H, Gagné SE, Clee S, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1996;1302:159-166.
12. Yang W-S, Nevin DN, Peng R, Brunzell JD, Deeb SS. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci U S A. 1995;92:4462-4466 (Correction: Proc Natl Acad Sci U S A. 1996;93:524).
13. Yang W-S, Nevin DN, Iwasaki L, Peng R, Brown BG, Brunzell JD, Deeb SS. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res. 1996;37:2627-2637.
14. Brunzell JD, Albers JJ, Chait A, Grundy SM, Grosek E, McDonald GB. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res. 1983;24:147-155.
15. Talmud PJ, Hall S, Chu G, Ginsberg H, Ramakrishnan R, Miller G, Humphries S. Lipoprotein lipase -93T/G transition is associated with lower plasma triglyceride levels and increases promoter activity in vitro. Circulation 1996;94(suppl 1):I-273.
16. Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, Obermann-de Boer GL, Kromhout D. Cardiovascular risk factors in the Netherlands. Neth J Cardiol. 1993;4:205-210.
17. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med. 1975;4:518-525.
18. Greenberg LJ, Martell RW, Theilman J, Hayden MR, Joubert J. Genetic linkage between Huntington disease and the D4S10 locus in South African families: further evidence against non-allelic heterogeneity. Hum Genet. 1991;87:701-708.
19. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977;74:1245-1249.
20. Wood S, Schertzer M, Hayden MR, Ma Y. Support of founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene. Hum Genet. 1993;91:312-316.
21. Friedewald WT, Levy RJ, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultra-centrifuge. Clin Chem. 1972;18:499-502.
22. Gonzales GA, Estrada M, Rodriguez Ferrer CR, Astarioa IR, Lahera EM. Use of serum cholesterol/triglyceride ratio to discern for which individuals the Friedewald formula can be used confidently. Clin Chem. 1990;36:1673-1675.
23. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity 1974;33:229-239.
24. Zechner R, Newman TC, Steiner E, Breslow JL. The structure of the mouse lipoprotein lipase gene: a B1 repetitive element is inserted into the 3′ untranslated region of the mRNA. Genomics 1991;11:62-76.